222 related articles for article (PubMed ID: 2417056)
21. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
Mathieu MC; Caillaud JM
Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
[TBL] [Abstract][Full Text] [Related]
22. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
Bentvelsen FM; Bogdanowicz JF; Oosterom R; Schröder FH
Ned Tijdschr Geneeskd; 1990 Aug; 134(33):1596-600. PubMed ID: 1697651
[TBL] [Abstract][Full Text] [Related]
23. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
[TBL] [Abstract][Full Text] [Related]
24. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.
Nadji M; Tabei SZ; Castro A; Chu TM; Murphy GP; Wang MC; Morales AR
Cancer; 1981 Sep; 48(5):1229-32. PubMed ID: 6168364
[TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemical diagnosis of a case of metastatic prostate cancer to breast].
Gotoh A; Matsuura K; Yoshimura S; Takano Y
Nihon Hinyokika Gakkai Zasshi; 1989 Dec; 80(12):1828-31. PubMed ID: 2483185
[TBL] [Abstract][Full Text] [Related]
26. Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostatic specific antigen by immunohistochemistry.
Vernon SE; Williams WD
J Urol; 1983 Jul; 130(1):95-8. PubMed ID: 6191050
[TBL] [Abstract][Full Text] [Related]
27. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
Bartziota EV
Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
[TBL] [Abstract][Full Text] [Related]
28. Prostatic origin of tumors. An immunohistochemical study.
Nadji M; Tabei SZ; Castro A; Chu TM; Morales AR
Am J Clin Pathol; 1980 Jun; 73(6):735-9. PubMed ID: 6156593
[TBL] [Abstract][Full Text] [Related]
29. Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase.
Yam LT; Winkler CF; Janckila AJ; Li CY; Lam KW
Cancer; 1983 Jan; 51(2):283-7. PubMed ID: 6336978
[TBL] [Abstract][Full Text] [Related]
30. Adenocarcinoma of the prostate involving 2 cell types (prostate specific antigen producing and carcinoembryonic antigen producing) with selective metastatic spread.
Guthman DA; Farrow GM; Myers RP; Ferrigni RG; Lieber MM
J Urol; 1991 Sep; 146(3):854-6. PubMed ID: 1714970
[TBL] [Abstract][Full Text] [Related]
31. Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy.
Grignon D; Troster M
Prostate; 1985; 7(2):195-202. PubMed ID: 2413432
[TBL] [Abstract][Full Text] [Related]
32. TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49.
Brenner PC; Rettig WJ; Sanz-Moncasi MP; Reuter V; Aprikian A; Old LJ; Fair WR; Garin-Chesa P
J Urol; 1995 May; 153(5):1575-9. PubMed ID: 7536270
[TBL] [Abstract][Full Text] [Related]
33. Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase.
Ferro MA; Barnes I; Roberts JB; Smith PJ
Br J Urol; 1987 Jul; 60(1):69-73. PubMed ID: 2441790
[TBL] [Abstract][Full Text] [Related]
34. The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice.
Daver A; Soret JY; Coblentz Y; Allain YM; Cellier P; Chauveau P
Am J Clin Oncol; 1988; 11 Suppl 2():S53-60. PubMed ID: 2468273
[TBL] [Abstract][Full Text] [Related]
35. Immunoperoxidase demonstration of prostatic acid phosphatase in aspiration biopsy cytology (ABC).
Keshgegian AA; Kline TS
Am J Clin Pathol; 1984 Nov; 82(5):586-9. PubMed ID: 6388312
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis.
Fan K
J Urol; 1988 Feb; 139(2):318-22. PubMed ID: 2448499
[TBL] [Abstract][Full Text] [Related]
37. The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates.
Warhol MJ; Longtine JA
J Urol; 1985 Sep; 134(3):607-13. PubMed ID: 2411954
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: are they helpful in staging prostatic cancer?
Morote J; Ruibal A; Pascual C; Palou J; de Torres JA
J Urol; 1987 May; 137(5):891-3. PubMed ID: 2437332
[TBL] [Abstract][Full Text] [Related]
39. Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.
Svanholm H; Hørder M
Scand J Urol Nephrol Suppl; 1988; 107():65-70. PubMed ID: 2453920
[TBL] [Abstract][Full Text] [Related]
40. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
